Comments on: Lisocabtagene Maraleucel Associated With Manageable Toxicities, Deep Responses in Relapsed/Refractory CLL or SLL https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/lisocabtagene-maraleucel-chronic-leukemia-treatment-risk-toxicities/ Sat, 14 Oct 2023 02:42:08 +0000 hourly 1 https://wordpress.org/?v=6.4.3